Antineoplastics - Drug Interactions

The antineoplastic drugs (also called cytotoxics or sometimes cytostatics) are used in treatment of malignant disease alone or in conjunction with radiotherapy, surgery or immunosuppressants. They also find application in treatment of a number of autoimmune disorders such as rheumatoid arthritis and psoriasis, and a few are used with other immunosuppressant drugs (ciclosporin, corticosteroids) to prevent transplant rejection. These other drugs are dealt with under section on immunosuppressants, .

Of all drugs discussed in this publication, antineoplastic drugs are amongst most toxic and have a low therapeutic index. This means that quite small increases in their levels can lead to development of serious and life-threatening toxicity. A list of antineoplastic drugs that are featured in this section appears in table 1 below,(below), grouped by their primary mechanism of action. This table also includes a number of hormone antagonists that are used in treatment of cancer.

Unlike most of other interaction monographs in this publication, some of information on antineoplastic drugs is derived from animal experiments and in vitro studies, so that confirmation of their clinical relevance is still needed. The reason for including these data is that anti-neoplastic drugs as a group do not lend themselves readily to kind of clinical studies that can be undertaken with many other drugs, and there would seem to be justification in this instance for including indirect evidence of this kind. The aim is not to make definite predictions, but to warn users of interaction possibilities.

1 Antineoplastics used in treatment of cancer

Alkylating agents,and drugs that appear to have an alkylating action

Carmustine,Lomustine, Streptozocin

Carboplatin,Cisplatin, Oxaliplatin

Altretamine,Busulfan, Chlorambucil, Chlormethine (Mechlorethamine), Cyclophosphamide, Dacarbazine, Estramustine, Ifosfamide, Melphalan, Temozolomide, Thiotepa

Methotrexate,Pemetrexed, Raltitrexed

Etoposide,Teniposide

Azathioprine,Cladribine, Fludarabine, Mercaptopurine, Tioguanine

Capecitabine,Carmofur, Cytarabine, Fluorouracil, Gemcitabine, Tegafur

Vinblastine,Vincristine, Vindesine, Vinorelbine

Docetaxel,Paclitaxel

Irinotecan,Topotecan, 9-Aminocamptothecin

Aclarubicin,Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone

Bleomycin,Dactinomycin, Mitomycin, Plicamycin

Bicalutamide,Flutamide, Nilutamide

Fulvestrant,Tamoxifen, Toremifene

Aminoglutethimide,Anastrozole, Exemestane, Formestane, Letrozole

Amsacrine,Asparaginase (Colaspase, Crisantaspase, Pegaspargase), Bexarotene, Erlotinib, Hydroxycarbamide, Imatinib, Mitotane, Pentostatin, Procarbazine, Sorafenib, Thalidomide, Trastuzumab, Tretinoin

Table 1 Antineoplastics used in the treatment of cancer
Action Drugs
Alkylating agents, and drugs that appear to have an alkylating action
Nitrosoureas Carmustine, Lomustine, Streptozocin
Platinum derivatives Carboplatin, Cisplatin, Oxaliplatin
Others Altretamine, Busulfan, Chlorambucil, Chlormethine (Mechlorethamine), Cyclophosphamide, Dacarbazine, Estramustine, Ifosfamide, Melphalan, Temozolomide, Thiotepa
Antimetabolites
Folate antagonists Methotrexate, Pemetrexed, Raltitrexed
Podophylotoxin derivatives Etoposide, Teniposide
Purine analogues Azathioprine, Cladribine, Fludarabine, Mercaptopurine, Tioguanine
Pyridmidine analogues Capecitabine, Carmofur, Cytarabine, Fluorouracil, Gemcitabine, Tegafur
Mitotic inhibitors
Vinca alkaloids Vinblastine, Vincristine, Vindesine, Vinorelbine
Taxanes Docetaxel, Paclitaxel
Topoisomerase inhibitors Irinotecan, Topotecan, 9-Aminocamptothecin
Cytotoxic antibiotics
Anthracyclines Aclarubicin, Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone
Others Bleomycin, Dactinomycin, Mitomycin, Plicamycin
Anti-androgens Bicalutamide, Flutamide, Nilutamide
Anti-oestrogens
Oestrogen-receptor antagonists Fulvestrant, Tamoxifen, Toremifene
Aromatase inhibitors Aminoglutethimide, Anastrozole, Exemestane, Formestane, Letrozole
Miscellaneous Amsacrine, Asparaginase (Colaspase, Crisantaspase, Pegaspargase), Bexarotene, Erlotinib, Hydroxycarbamide, Imatinib, Mitotane, Pentostatin, Procarbazine, Sorafenib, Thalidomide, Trastuzumab, Tretinoin